BATF/RORgt/IL-17 Axis as a Therapeutic Target in Systemic Lupus Erythematosus: Integrative Bioinformatics and In Vivo Validation of Langchuangding Combined with Prednisone. ACTA [Internet]. 2026 Jun. 16 [cited 2026 Jun. 27];89. Available from: https://acta-be.org/index.php/ACTA/article/view/58